Lonza | LONN - Nettoeinkommen

Aktienkurs
516.60
Täglich Wechseln
-9.00 -1.71%
Monatlich
-0.12%
Jährlich
-9.46%
Q1 Prognose
523.22




Nettoeinkommen Veränderung Datum
Akzo Nobel EUR 598M 792M 2025-12
Alcon AG USD 217M 20M 2025-12
Almirall EUR 19.58M 7M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
BASF EUR 560M 388M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Beiersdorf EUR 387M 165M 2025-12
Covestro EUR -378M 331M 2025-12
Demant DKK 427M 690M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 327M 52.2M 2025-12
Geberit CHF 151.2M 36.1M 2025-06
Genmab DKK 336M 141M 2025-06
Givaudan CHF 294M 150M 2024-06
GlaxoSmithKline GBP 636M 1.38B 2025-12
GN Store Nord DKK 344M 271M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Johnson Matthey GBP -18M 93M 2025-12
Merck EUR 902M 250M 2025-09
Novartis USD 3.93B 96M 2025-09
Philips EUR 395M 211M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sika AG CHF 553.8M 115.8M 2025-06
Smith & Nephew USD 293M 79M 2025-12
Solvay EUR -95M 129M 2025-12
UCB EUR 857M 649M 2024-12